Literature DB >> 16904870

IL-2 receptor alpha deficiency and features of primary biliary cirrhosis.

Christopher A Aoki1, Chaim M Roifman, Zhe-Xiong Lian, Christopher L Bowlus, Gary L Norman, Yehuda Shoenfeld, Ian R Mackay, M Eric Gershwin.   

Abstract

Congenital immune deficiency states have often been valuable experimental models of nature that have significantly enhanced our understanding of the immune response. The relationship between CD4+, CD25+ and Treg cells in the induction of autoimmunity has attracted significant attention. We report herein a male child of consanguineous parents who developed at six months recurrent infections, and at age 5 years, liver dysfunction with serological expression of primary biliary cirrhosis (PBC), an autoimmune liver disease that usually affects middle-aged women. Histologically, there was intense mononuclear cell lymphoid infiltration of the intrahepatic portal tracts, CD3+CD4+T cell lymphopenia in blood and serum antibody to PDC-E2. Peripheral blood lymphocytes were completely deficient of the alpha subunit of the IL-2 receptor (IL-2Ralpha, CD 25), a marker for regulatory T cells (Tregs). Allogenic stem cell transplantation led to full recovery. This case illustrates the role of deficiency of CD4+CD25+ Treg cells in causing autoimmunity, and speaks to the potential use of allogenic stem cell transplantation for immunoreconstitution in adult PBC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16904870     DOI: 10.1016/j.jaut.2006.04.005

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  65 in total

1.  Increased ΤGF-β3 in primary biliary cirrhosis: an abnormality related to pathogenesis?

Authors:  Argyro Voumvouraki; Mairi Koulentaki; Maria Tzardi; Ourania Sfakianaki; Penelope Manousou; George Notas; Elias Kouroumalis
Journal:  World J Gastroenterol       Date:  2010-10-28       Impact factor: 5.742

2.  Dermal immunopathology: from genetics to effector mechanisms.

Authors:  Akira Takashima; Fu-Tong Liu
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 8.667

3.  Combination of rapamycin and IL-2 increases de novo induction of human CD4(+)CD25(+)FOXP3(+) T cells.

Authors:  S Alice Long; Jane H Buckner
Journal:  J Autoimmun       Date:  2008-03-03       Impact factor: 7.094

4.  Vasculitis: current status and future directions.

Authors:  Pierre Youinou
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

5.  Cutting edge issues in autoimmunity.

Authors:  Yaniv Sherer; Torsten Matthias; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2008-06       Impact factor: 8.667

Review 6.  Genetics and genomics of primary biliary cirrhosis.

Authors:  Brian D Juran; Konstantinos N Lazaridis
Journal:  Clin Liver Dis       Date:  2008-05       Impact factor: 6.126

7.  Adoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice.

Authors:  Guo-Xiang Yang; Zhe-Xiong Lian; Ya-Hui Chuang; Yuki Moritoki; Ruth Y Lan; Kanji Wakabayashi; Aftab A Ansari; Richard A Flavell; William M Ridgway; Ross L Coppel; Koichi Tsuneyama; Ian R Mackay; M Eric Gershwin
Journal:  Hepatology       Date:  2008-06       Impact factor: 17.425

Review 8.  Role of autoimmunity in primary biliary cirrhosis.

Authors:  Tian-Yan Shi; Feng-Chun Zhang
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

Review 9.  Animal models of primary biliary cirrhosis.

Authors:  Ya-Hui Chuang; William M Ridgway; Yoshiyuki Ueno; M Eric Gershwin
Journal:  Clin Liver Dis       Date:  2008-05       Impact factor: 6.126

10.  Nanofibrous Spongy Microspheres To Distinctly Release miRNA and Growth Factors To Enrich Regulatory T Cells and Rescue Periodontal Bone Loss.

Authors:  Zhongning Liu; Xin Chen; Zhanpeng Zhang; Xiaojin Zhang; Laura Saunders; Yongsheng Zhou; Peter X Ma
Journal:  ACS Nano       Date:  2018-08-29       Impact factor: 15.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.